4,8-Dichloro-2-(trifluoromethyl)quinoline - CAS 18706-35-9
Catalog: |
BB014391 |
Product Name: |
4,8-Dichloro-2-(trifluoromethyl)quinoline |
CAS: |
18706-35-9 |
Synonyms: |
4,8-dichloro-2-(trifluoromethyl)quinoline; 4,8-dichloro-2-(trifluoromethyl)quinoline |
IUPAC Name: | 4,8-dichloro-2-(trifluoromethyl)quinoline |
Description: | 4,8-Dichloro-2-(trifluoromethyl)quinoline (CAS# 18706-35-9) is a useful research chemical. |
Molecular Weight: | 266.05 |
Molecular Formula: | C10H4Cl2F3N |
Canonical SMILES: | C1=CC2=C(C(=C1)Cl)N=C(C=C2Cl)C(F)(F)F |
InChI: | InChI=1S/C10H4Cl2F3N/c11-6-3-1-2-5-7(12)4-8(10(13,14)15)16-9(5)6/h1-4H |
InChI Key: | ILLBOMMZLXFMAY-UHFFFAOYSA-N |
Boiling Point: | 271.8 °C at 760 mmHg |
Melting Point: | 60-63 °C |
Purity: | 97 % |
Density: | 1.527 g/cm3 |
Appearance: | White to light yellow crystal powder |
MDL: | MFCD00276590 |
LogP: | 4.56040 |
GHS Hazard Statement: | H302 (20%): Harmful if swallowed [Warning Acute toxicity, oral]; H312 (20%): Harmful in contact with skin [Warning Acute toxicity, dermal]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H332 (20%): Harmful if inhaled [Warning Acute toxicity, inhalation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
AU-2001277754-B2 | Proline derivatives and use thereof as drugs | 20000810 |
BR-PI0113146-B1 | "PROLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION UNDERSTANDING THEM". | 20000810 |
CA-2418656-C | Proline derivatives and use thereof as drugs | 20000810 |
EP-1308439-A1 | Proline derivatives and use thereof as drugs | 20000810 |
EP-1308439-A8 | Proline derivatives and use thereof as drugs | 20000810 |
Complexity: | 259 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 264.967289 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 264.967289 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 12.9 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 4.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoline/Isoquinoline
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS